| Systematic review: antibodies and anti‐TNF‐α levels in inflammatory bowel disease M Chaparro, I Guerra, P Muñoz‐Linares, JP Gisbert Alimentary pharmacology & therapeutics 35 (9), 971-986, 2012 | 120 | 2012 |
| Two-stage treatment with preoperative endoscopic retrograde cholangiopancreatography (ERCP) compared with single-stage treatment with intraoperative ERCP for patients with … LR Rábago, C Vicente, F Soler, M Delgado, I Moral, I Guerra, JL Castro, ... Endoscopy 38 (08), 779-786, 2006 | 103 | 2006 |
| Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: a report of 21 cases I Guerra, A Algaba, JL Pérez-Calle, M Chaparro, I Marín-Jiménez, ... Journal of Crohn's and Colitis 6 (5), 518-523, 2012 | 82 | 2012 |
| Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients JP Gisbert, A Perez-Aisa, F Bermejo, M Castro-Fernandez, P Almela, ... Journal of clinical gastroenterology 47 (2), 130-135, 2013 | 65 | 2013 |
| Incidence, clinical characteristics, and management of psoriasis induced by anti-TNF therapy in patients with inflammatory bowel disease: a nationwide cohort study I Guerra, T Pérez-Jeldres, M Iborra, A Algaba, D Monfort, X Calvet, ... Inflammatory bowel diseases 22 (4), 894-901, 2016 | 46 | 2016 |
| Efficacy of different therapeutic options for spontaneous abdominal abscesses in Crohn's disease: are antibiotics enough? F Bermejo, E Garrido, M Chaparro, J Gordillo, M Mañosa, A Algaba, ... Inflammatory bowel diseases 18 (8), 1509-1514, 2011 | 45 | 2011 |
| Should we monitor vitamin B12 and folate levels in Crohn's disease patients? F Bermejo, A Algaba, I Guerra, M Chaparro, G De-La-Poza, P Valer, ... Scandinavian journal of gastroenterology 48 (11), 1272-1277, 2013 | 42 | 2013 |
| Long-Term Safety ofIn UteroExposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study M Chaparro, A Verreth, T Lobaton, E Gravito-Soares, M Julsgaard, ... American Journal of Gastroenterology 113 (3), 396-403, 2018 | 38 | 2018 |
| Tuberculosis in anti-tumour necrosis factor-treated inflammatory bowel disease patients after the implementation of preventive measures: compliance with recommendations and … D Carpio, A Jauregui-Amezaga, R De Francisco, L de Castro, ... Journal of Crohn's and Colitis 10 (10), 1186-1193, 2016 | 31 | 2016 |
| Factors that modify therapy adherence in patients with inflammatory bowel disease F Bermejo, ALS Román, A Algaba, I Guerra, P Valer, S García-Garzón, ... Journal of Crohn's and Colitis 4 (4), 422-426, 2010 | 31 | 2010 |
| Management of inflammatory bowel disease in poor responders to infliximab I Guerra, F Bermejo Clinical and experimental gastroenterology 7, 359, 2014 | 26 | 2014 |
| Is outpatient ERCP suitable, feasible, and safe? The experience of a Spanish community hospital L Rábago, I Guerra, M Moran, E Quintanilla, D Collado, I Chico, ... Surgical endoscopy 24 (7), 1701-1706, 2010 | 26 | 2010 |
| Mercaptopurine rescue after azathioprine‐induced liver injury in inflammatory bowel disease F Bermejo, A LÓPEZ‐SANROMÁN, A Algaba, M VAN‐DOMSELAAR, ... Alimentary pharmacology & therapeutics 31 (1), 120-124, 2010 | 24 | 2010 |
| Incidence, management, and course of cancer in patients with inflammatory bowel disease A Algaba, I Guerra, I Marín-Jiménez, E Quintanilla, P López-Serrano, ... Journal of Crohn's and Colitis 9 (4), 326-333, 2015 | 22 | 2015 |
| Relationship between levels of angiogenic and lymphangiogenic factors and the endoscopic, histological and clinical activity, and acute-phase reactants in patients with … A Algaba, PM Linares, ME Fernández-Contreras, A Ordoñez, J Trápaga, ... Journal of Crohn's and Colitis 7 (11), e569-e579, 2013 | 22 | 2013 |
| Utility of measuring serum concentrations of anti-TNF agents and anti-drug antibodies in inflammatory bowel disease I Guerra, M Chaparro, F Bermejo, J P Gisbert Current drug metabolism 12 (6), 594-598, 2011 | 20 | 2011 |
| How frequently do tuberculosis screening tests convert in inflammatory bowel disease patients on anti-tumour necrosis factor-alpha? A pilot study F Bermejo, A Algaba, M Chaparro, C Taxonera, E Garrido, I García-Arata, ... Digestive and Liver Disease 45 (9), 733-737, 2013 | 17 | 2013 |
| Endoscopic treatment of gastrointestinal fistulas with biological fibrin glue LR Ramón, I Moral, M Delgado, I Guerra, E Quintanilla, JL Castro, ... Gastroenterologia y hepatologia 29 (7), 390-396, 2006 | 17 | 2006 |
| Evaluation of the quality of semen and sexual function in men with inflammatory bowel disease P Valer, A Algaba, D Santos, ME Fuentes, E Nieto, JP Gisbert, P López, ... Inflammatory bowel diseases 23 (7), 1144-1153, 2017 | 15 | 2017 |
| Onset of psoriasis in patients with inflammatory bowel disease treated with anti-TNF agents I Guerra, JP Gisbert Expert review of gastroenterology & hepatology 7 (1), 41-48, 2013 | 14 | 2013 |
